Literature DB >> 25600280

E-cadherin-negative acinar cell carcinoma of the pancreas: report of a case showing a solid pseudopapillary growth pattern.

Shogo Tajima1, Michihiko Waki2, Masaki Azuma3, Kenji Koda4, Akihiko Ohata5.   

Abstract

E-cadherin expression patterns in acinar cell carcinomas (ACCs) of the pancreas have not been well documented. Herein, we present a hitherto undescribed case of E-cadherin-negative ACC with a solid pseudopapillary growth pattern in a 65-year-old man. We used an antibody against the extracellular domain of E-cadherin. As a further unusual status in ACC, faint β-catenin expression was observed in the cytoplasm of carcinoma cells. Morphological distinction from a solid pseudopapillary neoplasm (SPN) of the pancreas might be problematic in such a case, because of their similarities concerned with the growth pattern and E-cadherin negativity. Without nuclear accumulation of β-catenin, a diagnosis of SPN was almost excluded. Immunoreactivity for trypsin and BCL10 made an accurate diagnosis of ACC to this case. The tumor recurred 10 months post-surgery as rapidly enlarging masses in the liver, presumably indicating the aggressiveness of the E-cadherin-negative phenotype among ACCs.

Entities:  

Keywords:  Acinar cell carcinoma; E-cadherin; Pancreas; Solid pseudopapillary; β-catenin

Mesh:

Substances:

Year:  2015        PMID: 25600280     DOI: 10.1007/s00795-015-0095-2

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  15 in total

Review 1.  The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin.

Authors:  Jack Lilien; Janne Balsamo
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

2.  Membrane loss and aberrant nuclear localization of E-cadherin are consistent features of solid pseudopapillary tumour of the pancreas. An immunohistochemical study using two antibodies recognizing different domains of the E-cadherin molecule.

Authors:  R Chetty; S Serra
Journal:  Histopathology       Date:  2008-02       Impact factor: 5.087

Review 3.  The E-cadherin/catenin complex in invasion and metastasis.

Authors:  M E Bracke; F M Van Roy; M M Mareel
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

4.  Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.

Authors:  Susan C Abraham; David S Klimstra; Robb E Wilentz; Charles J Yeo; Kevin Conlon; Murray Brennan; John L Cameron; Tsung-Teh Wu; Ralph H Hruban
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

5.  Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.

Authors:  Susan C Abraham; Tsung-Teh Wu; Ralph H Hruban; Jae-Hyuk Lee; Charles J Yeo; Kevin Conlon; Murray Brennan; John L Cameron; David S Klimstra
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

6.  Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature.

Authors:  Akhil K Seth; Pedram Argani; Kurtis A Campbell; John L Cameron; Timothy M Pawlik; Richard D Schulick; Michael A Choti; Christopher L Wolfgang
Journal:  J Gastrointest Surg       Date:  2007-10-24       Impact factor: 3.452

7.  Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.

Authors:  Mi-Jung Kim; Se-Jin Jang; Eunsil Yu
Journal:  Hum Pathol       Date:  2007-10-24       Impact factor: 3.466

8.  Nonductal neoplasms of the pancreas.

Authors:  David S Klimstra
Journal:  Mod Pathol       Date:  2007-02       Impact factor: 7.842

Review 9.  Revision 2: an immunohistochemical approach and evaluation of solid pseudopapillary tumour of the pancreas.

Authors:  S Serra; R Chetty
Journal:  J Clin Pathol       Date:  2008-08-15       Impact factor: 3.411

10.  The monoclonal anti-BCL10 antibody (clone 331.1) is a sensitive and specific marker of pancreatic acinar cell carcinoma and pancreatic metaplasia.

Authors:  Stefano La Rosa; Francesca Franzi; Silvia Marchet; Giovanna Finzi; Moira Clerici; Davide Vigetti; Anna Maria Chiaravalli; Fausto Sessa; Carlo Capella
Journal:  Virchows Arch       Date:  2008-12-09       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.